Analysts Set Expectations for Prime Medicine FY2025 Earnings
Prime Medicine, Inc. (NYSE:PRME – Free Report) – Equities researchers at Chardan Capital dropped their FY2025 EPS estimates for shares of Prime Medicine in a research note issued on Monday, May 12th. Chardan Capital analyst G. Livshits now forecasts that the company will post earnings per share of ($1.39) for the year, down from their […]
Prime Medicine, Inc. (NYSE:PRME – Free Report) – Equities researchers at Chardan Capital dropped their FY2025 EPS estimates for shares of Prime Medicine in a research note issued on Monday, May 12th. Chardan Capital analyst G. Livshits now forecasts that the company will post earnings per share of ($1.39) for the year, down from their […]
